Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · IEX Real-Time Price · USD
405.63
+5.71 (1.43%)
Apr 23, 2024, 11:33 AM EDT - Market open

Vertex Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1994
Revenue
9,8698,9317,5746,2064,1633,0482,4891,7021,032580.42
Upgrade
Revenue Growth (YoY)
10.51%17.91%22.06%49.08%36.59%22.46%46.20%64.89%77.86%-52.11%
Upgrade
Cost of Revenue
1,2621,080904.2736.3547.8409.54275.12210.46124.5160.99
Upgrade
Gross Profit
8,6077,8506,6705,4693,6152,6382,2141,492907.82519.43
Upgrade
Selling, General & Admin
1,137944.7840.1770.5658.5557.62496.08432.83376.58305.41
Upgrade
Research & Development
3,1632,5401,9381,6451,7551,4161,3251,048995.92855.51
Upgrade
Other Operating Expenses
527.1115.51,113184.6028.82269.591.262.2150.93
Upgrade
Operating Expenses
4,8273,6013,8912,6002,4132,0032,0901,4821,3751,212
Upgrade
Operating Income
3,7804,2502,7792,8691,202635.15123.249.94-466.88-692.41
Upgrade
Interest Expense / Income
44.154.861.558.258.572.4769.381.4384.2172.86
Upgrade
Other Expense / Income
-643.5-37.3-12.9-305.7-251.4-47.36-102.2223.89-25.13-33.68
Upgrade
Pretax Income
4,3804,2322,7303,1171,395610.03156.16-95.39-525.95-731.6
Upgrade
Income Tax
760.2910.4388.3405.2218.1-1,486.86-107.3216.6730.386.96
Upgrade
Net Income
3,6203,3222,3422,7121,1772,097263.48-112.05-556.33-738.56
Upgrade
Net Income Growth
8.96%41.84%-13.63%130.43%-43.88%695.83%----
Upgrade
Shares Outstanding (Basic)
258256258260257254249245241235
Upgrade
Shares Outstanding (Diluted)
261259260263261259253245241235
Upgrade
Shares Change
0.54%-0.31%-1.33%1.04%0.58%2.35%3.49%1.40%2.55%4.62%
Upgrade
EPS (Basic)
14.0512.979.0910.444.588.241.06-0.46-2.31-3.14
Upgrade
EPS (Diluted)
13.8912.829.0110.294.518.091.04-0.46-2.31-3.14
Upgrade
EPS Growth
8.35%42.29%-12.44%128.16%-44.25%677.88%----
Upgrade
Free Cash Flow
3,3373,9252,4092,9941,4941,175745.52179.54-410.73-624.31
Upgrade
Free Cash Flow Per Share
12.9515.339.3511.525.824.623.000.73-1.70-2.65
Upgrade
Gross Margin
87.21%87.90%88.06%88.14%86.84%86.56%88.95%87.64%87.94%89.49%
Upgrade
Operating Margin
38.31%47.59%36.69%46.24%28.87%20.84%4.95%0.58%-45.23%-119.30%
Upgrade
Profit Margin
36.68%37.20%30.92%43.70%28.27%68.80%10.59%-6.58%-53.89%-127.25%
Upgrade
Free Cash Flow Margin
33.81%43.95%31.80%48.24%35.89%38.55%29.96%10.55%-39.79%-107.56%
Upgrade
Effective Tax Rate
17.36%21.51%14.22%13.00%15.64%-243.73%-68.73%---
Upgrade
EBITDA
4,6054,4362,9183,2851,560754.93286.8647.44-379.4-595.48
Upgrade
EBITDA Margin
46.66%49.67%38.52%52.93%37.48%24.77%11.53%2.79%-36.75%-102.60%
Upgrade
Depreciation & Amortization
181.3148.3125.6109.5106.972.4261.461.462.3463.26
Upgrade
EBIT
4,4244,2872,7923,1751,453682.51225.46-13.96-441.75-658.73
Upgrade
EBIT Margin
44.83%48.01%36.86%51.16%34.91%22.39%9.06%-0.82%-42.79%-113.49%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).